Over the past several decades, accelerating scientific and technological advances have enabled researchers to make a great quantity of knowledge in the field of cancer biology. Numerous genes, mutant alleles, proteins, and signalling networks involved in the initiation and progression of cancer have been identified and some of the mechanisms deliberating resistance to therapy. Because of the limited efficacy of presently available treatment modalities, the cancer results to death and distress. One of the most important and complicated topics about the cancer is cancer stem cells (CSCs). The CSCs are immortal tumor-initiating cells that share some characteristics with normal stem/progenitor cells. Some of their important characteristics are self-renewal and multilineage differentiation. Since CSCs have potential resistance to chemotherapeutic agents as well as radiation therapy, it makes a serious challenge for current cancer treatments. 
Pharmacological Targeting
Small molecule inhibitors have shown promising results when are used alone or in combination to target slow growing chemo-and radio-resistant CSCs. Several strategies have been employed including targeting signalling pathways that affect chemo-and radio-resistance to CSCs, thus increasing their susceptibility to conventional therapies (13) .
Immunotherapy
Cancer stem cells have been associated with immunosuppressive properties (14) , which are likely a critical part of the mechanism which provides the cells with tumor-promoting and immunomodulatory characteristics. Understanding the many different immunosuppressive pathways in CSCs allows for a more effective design of therapeutic elimination strategies (13) .
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Conclusion
The identification of CSCs and the recent knowledge about their ability to resist common radio-and chemotherapy have urged a number of new targeting strategies to attack this rare but extremely important tumor subpopulation in order to eradicate cancer. It is necessary to mention focusing on CSCs' markers and related signaling pathways, have been also useful tools to find appropriate therapies. However, the CSC paradigm has provided exciting novel venues to improve cancer treatment by lowering recurrence and metastasis, which are considered to be the main cause of most cancer mortalities.
